| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Hunger | 14.03.02.012; 08.01.09.003 | 0.051208% | | Not Available |
| Hyperaesthesia | 23.03.03.080; 17.02.06.004 | - | - | Not Available |
| Hyperglycaemia | 05.06.02.002; 14.06.02.002 | - | - | |
| Hyperhidrosis | 23.02.03.004; 08.01.03.028 | 0.022090% | | |
| Hypersensitivity | 10.01.03.003 | - | - | |
| Hyperventilation | 22.02.01.006; 19.01.02.004 | - | - | Not Available |
| Hypervolaemia | 02.05.04.019; 14.05.06.003 | - | - | Not Available |
| Hypoaesthesia | 17.02.06.023; 23.03.03.081 | 0.051208% | | Not Available |
| Hypokinesia | 17.01.02.009 | - | - | Not Available |
| Hypoxia | 22.02.02.003 | - | - | |
| Immune system disorder | 10.02.01.001 | - | - | Not Available |
| Impaired gastric emptying | 07.02.02.004 | - | - | |
| Impaired healing | 08.03.02.001 | - | - | Not Available |
| Incoherent | 19.10.03.006; 17.02.08.002 | - | - | Not Available |
| Infertility female | 21.03.02.017 | - | - | Not Available |
| Inflammatory bowel disease | 07.08.01.016 | - | - | Not Available |
| Influenza like illness | 08.01.03.010 | - | - | |
| Injection site bruising | 23.03.11.015; 08.02.03.042; 24.07.06.017; 12.07.03.042 | - | - | Not Available |
| Injection site erythema | 23.03.06.015; 12.07.03.001; 08.02.03.001 | 0.670723% | | Not Available |
| Injection site haematoma | 12.07.03.004; 08.02.03.004; 24.07.01.009 | - | - | Not Available |
| Injection site haemorrhage | 24.07.01.010; 12.07.03.005; 08.02.03.005 | - | - | Not Available |
| Injection site hypersensitivity | 12.07.03.006; 10.01.03.017; 08.02.03.006 | - | - | Not Available |
| Injection site induration | 12.07.03.007; 08.02.03.007 | 0.068277% | | Not Available |
| Injection site infection | 12.07.03.008; 11.01.08.005; 08.02.03.019 | - | - | Not Available |
| Injection site inflammation | 08.02.03.008; 12.07.03.009 | - | - | Not Available |
| Injection site mass | 12.07.03.010; 08.02.03.009 | 0.175713% | | Not Available |
| Injection site necrosis | 08.02.03.020; 12.07.03.020 | - | - | Not Available |
| Injection site pain | 12.07.03.011; 08.02.03.010 | 0.341386% | | Not Available |
| Injection site pruritus | 23.03.12.007; 12.07.03.014; 08.02.03.013 | 0.238970% | | Not Available |
| Injection site rash | 23.03.13.010; 12.07.03.032; 08.02.03.032 | 0.153624% | | Not Available |